Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological control mechanisms in plaque formation

G K Hansson1

  • 1Gothenburg University, Department of Clinical Chemistry, Sahlgren's Hospital, Sweden.

Basic Research in Cardiology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.

Journal of internal medicine·2020
Same author

Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.

Journal of internal medicine·2020
Same author

Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.

Journal of internal medicine·2017
Same author

Gene expression signatures, pathways and networks in carotid atherosclerosis.

Journal of internal medicine·2015
Same author

The changing face of atherosclerotic plaque inflammation.

Journal of internal medicine·2015
Same author

Inflammation and plaque vulnerability.

Journal of internal medicine·2015

This study reveals that interferon-gamma, a T cell cytokine, combats atherosclerosis by reducing cholesterol buildup and foam cell formation. It also inhibits smooth muscle proliferation and restenosis, highlighting crucial vascular-immune interactions in disease.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Genetics

Background:

  • Atherosclerosis involves cholesterol accumulation, inflammation, and fibrous tissue formation within arterial plaques.
  • T lymphocyte activation and cytokine secretion are observed in atherosclerotic lesions, suggesting immune involvement.

Purpose of the Study:

  • To analyze inflammatory components in atherosclerotic plaques.
  • To investigate the vascular effects of cytokines produced by plaque macrophages and lymphocytes.
  • To understand the role of T cell-derived cytokines in atherosclerosis pathogenesis.

Main Methods:

  • Molecular genetical characterization of T cell clones from atherosclerotic lesions.
  • Analysis of T lymphocyte activation and cytokine secretion.

Related Experiment Videos

  • Cell culture and animal experiments to study vascular effects of cytokines.
  • Investigating the impact of interferon-gamma on macrophage scavenger receptors and smooth muscle cell proliferation.

    • Main Results:

    • T cell clones from lesions are heterogeneous, indicating diverse progenitors and antigenic epitope responses.
    • The T cell cytokine interferon-gamma inhibits cholesterol accumulation and foam cell formation by down-regulating macrophage scavenger receptors.
    • Interferon-gamma also inhibits smooth muscle proliferation in vitro and arterial restenosis post-angioplasty in vivo.

    Conclusions:

    • Vascular-immune interactions are critical in the pathogenesis of atherosclerosis.
    • Interferon-gamma plays a protective role by modulating key cellular processes in atherosclerosis.
    • Further research is needed to identify specific antigenic epitopes and the extent of local immune response within plaques.